Add Company
Join Now

CMTx Biotech Revenue and Competitors

License our Company Data API

Stony Brook, NY

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CMTx Biotech's estimated annual revenue is currently $1.7M per year.(i)
  • CMTx Biotech's estimated revenue per employee is $155,000

Employee Data

  • CMTx Biotech has 11 Employees.(i)
  • CMTx Biotech grew their employee count by 22% last year.

CMTx Biotech's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is CMTx Biotech?

CMTx Biotech is a clinical-stage biopharmaceutical company that is aggressively developing an orally-administered small molecule for the treatment of COVID-19 patients. The company is currently preparing to advance into a Phase II clinical trial to demonstrate the safety and efficacy of our lead drug candidate in hospitalized COVID-19 patients. Our clinical-stage drug candidate has already demonstrated impressive efficacy in a number of animal models of acute respiratory distress syndrome (ARDS) across multiple species (rats, mice, pigs, sheep). It has also been evaluated in several Phase I/II clinical studies, which showed that the drug is well-tolerated. CMTx Biotech also has a pipeline of pre-clinical stage analogues for the treatment of rare diseases.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M12140%N/A
#2
$3.7M2420%N/A
#3
$2.5M259%N/A
#4
$3.5M30-33%N/A
#5
$8.1M3182%N/A